Procter & Gamble FY 2026 core EPS rose 1% to $6.89; fourth-quarter core EPS fell 3%
Procter & Gamble reported fiscal 2026 and fourth-quarter results on July 29, 2026, and provided fiscal 2027 guidance with slides filed as Exhibit 99.1. Full-year core EPS rose 1% to $6.89, while fourth-quarter core EPS fell 3% to $1.43, and the company guided fiscal 2027 core EPS growth of 0% to 3%, with first-quarter core EPS expected to fall 5% or more.
Key points
- Fiscal 2026 organic sales grew 1% and core EPS was $6.89, up from $6.83 in the prior year on a core basis.
- Fourth-quarter core EPS was $1.43 versus $1.48 a year earlier; currency-neutral core EPS fell 5% to $1.41.
- Fiscal 2027 guidance: organic sales growth of 1% to 3%, core EPS growth of 0% to 3%, and all-in EPS growth of 1% to 5%.
- Company guided first-quarter fiscal 2027 EPS down 5% or more and cited about $1 billion after-tax higher energy, transportation and raw material costs.
The filing
Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 29, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.